Aquestive Therapeutics, Inc. (AQST)
Nasdaq: AQST · Pharmaceutical Preparations · Warren, NJ · filing with the SEC since 2007
Who runs Aquestive Therapeutics, Inc.
Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filedChief executive, as filed
Barber Daniel
President and CEO. First filing Jul 2018, latest Oct 16, 2026, 12 filings in all.
Officers reporting now
11
of 18 people with a filing in the last fifteen months
Directors reporting now
7
30 people on the record since 2018
Officerssales are open-market, Nov 12, 2025 to Nov 12, 2026
| Name | Title as filed | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Davis Matthew W. | Chief Development Officer | Nov 2025 | Nov 12, 2026 | none |
| Barber Daniel | President and CEO | Jul 2018 | Oct 16, 2026 | 8 · $1.3M |
| Korczynski Sherry | Chief Commercial Officer | Jun 2024 | Sep 11, 2026 | 2 · $100,000 |
| Boyd Peter E. | Chief People Officer | Jul 2018 | Sep 10, 2026 | 1 · $100,000 |
| Jung Cassie | Chief Operating Officer | Jan 2023 | Sep 8, 2026 | 1 · $200,000 |
| Zalewski Thomas A. | Chief Legal Officer | Apr 2026 | May 19, 2026 | none |
| Cioffi Melina | SVP, Regulatory Affairs | May 2025 | May 18, 2026 | 1 · $100,000 |
| Braender Lori J | Corporate Secretary | Sep 2018 | May 11, 2026 | 1 · $200,000 |
| Toth A Ernest Jr | Chief Financial Officer | Jan 2021 | May 7, 2026 | 1 · $200,000 |
| Greenhawt Matthew J. | Chief Medical Officer | Mar 2026 | Mar 11, 2026 | none |
| Kraus Carl N | Chief Medical Officer | Jun 2023 | Oct 17, 2025 | none |
Directorssales are open-market, Nov 12, 2025 to Nov 12, 2026
| Name | Role | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Daly Richard J | director | Nov 2026 | Nov 12, 2026 | none |
| Cochran John | director | Jul 2018 | Oct 23, 2026 | none |
| Krop Julie | director | Feb 2021 | Jun 24, 2026 | 1 · $100,000 |
| Brown Gregory B | director | Jul 2018 | Jun 12, 2026 | none |
| Jenkins Abigail L. | director | Apr 2024 | Jun 12, 2026 | none |
| Morris Timothy E | director | Aug 2022 | Jun 12, 2026 | none |
| Taglietti Marco | director | Feb 2021 | Jun 12, 2026 | none |
Earlier names on the record20, newest filing first
Wargacki Stephen · officer · last filing Mar 2025Bratton Douglas K · director · last filing Dec 2024Schobel Alexander Mark · officer · last filing Oct 2024Costa Santo J · director · last filing Jun 2024Marshall Ken W. · officer · last filing Aug 2023Truitt Kenneth · officer · last filing Sep 2022Kendall Keith J · officer · last filing Mar 2022Wood Theresa · officer · last filing Mar 2022Lurker Nancy · director · last filing Jun 2021Scibetta James S · director · last filing Jun 2021Bratton Capital Inc. · 10% owner · last filing Mar 2021Bratton Capital Management, L.P. · 10% owner · last filing Mar 2021Monoline Partners, L.P. · 10% owner · last filing Mar 2021Monoline Rx II, L.P. · 10% owner · last filing Mar 2021Monoline Rx III, L.P. · 10% owner · last filing Mar 2021Monoline Rx, L.P. · 10% owner · last filing Mar 2021Monosol Rx Genpar, L.P. · 10% owner · last filing Mar 2021Mrx Partners, LLC · 10% owner · last filing Mar 2021Maxwell John T. · officer · last filing Aug 2020Slatko Gary H · officer · last filing Mar 2020
A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.